[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Investigation Report on Chinese Dezocine Market, 2021-2025

April 2021 | 50 pages | ID: I1386AF3A50AEN
China Research and Intelligence Co., Ltd.

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative analgesia, and preemptive analgesia.

In the Chinese pharmaceutical market, narcotic analgesics have grown very fast in recent years, mainly due to massive surgeries in China. According to Chinese statistics, there will be more than 50 million operations in 2019, and the amount of surgeries is increasing year by year. In narcotic analgesics, Dezocine accounts for up to 60% of the market share.

According to CRI’s market research, the sales of Dezocine had a growth trend from 2016 to 2019. The revenue in 2020 was approximately CNY2.06 billion, though it decreased by 6.18% compared to 2019 due to the COVID-19 epidemic. The CAGR of sales from 2016 to 2020 is 8.77%. Therefore, CRI analyzes that, with the improvement of the epidemic situation, the sales of Dezocine in China are expected to have a recovery growth in 2021-2025.

Topics Covered:
  • The impact of COVID-19 on China's dezocine market
  • Sales value and volume of China's dezocine 2016-2020
  • Competitive landscape of China's dezocine market
  • Prices of dezocine in China
  • Prices of dezocine in China by regions and manufacturers
  • Analysis on factors affecting the development of China's dezocine market
  • Prospect of China's dezocine market from 2021 to 2025
1 RELEVANT CONCEPTS OF DEZOCINE

1.1 Indications for Dezocine
1.2 Development of Dezocine in China
1.3 Governmental Approval of Dezocine in China
1.4 The Impact of COVID-19 on Dezocine sales in China

2 SALES OF DEZOCINE IN CHINA, 2016-2020

2.1 Sales Value of Dezocine
  2.1.1 Overall Sales Value
  2.1.2 Sales Value by Region
2.2 Sales Volume of Dezocine
  2.2.1 Overall Sales Volume
  2.2.2 Sales Volume by Region
2.3 Sales of Dezocine by Dosage Form in China, 2016-2020
  2.3.1 Injection
  2.3.2 Analysis of Other Dosage Forms

3 ANALYSIS OF MAJOR DEZOCINE MANUFACTURERS IN CHINA, 2016-2020

3.1 Analysis of Market Share of Major Dezocine Manufacturers
  3.1.1 Investigation on Market Share by Sales Value
  3.1.2 Investigation on Market Share by Sales volume
3.2 Yangtze River Pharmaceutical Group
  3.2.1 Enterprise Profile
  3.2.2 Sales of Jialuoning (YRPG's Dezocine) in China
3.3 Nanjing Yoko Pharmaceutical Co., Ltd.
  3.3.1 Enterprise Profile
  3.3.2 Sales of Yikeding (Nanjing Yoko's Dezocine) in China

4 PRICES OF DEZOCINE FOR DIFFERENT MANUFACTURERS IN CHINA, 2020-2021

4.1 Yangtze River Pharmaceutical Group (Jialuoning)
4.2 Nanjing Yoko Pharmaceutical Co., Ltd. (Yikeding)

5 PROSPECT OF CHINESE DEZOCINE DRUG MARKET, 2021-2025

5.1 Influential Factors of Chinese Dezocine Market Development
  5.1.1 The Impact of COVID-19 on Chinese Dezocine Market
  5.1.2 Market Drivers and Opportunities
  5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

LIST OF CHARTS

Chart Patent Information About Dezocine Injection Registration in China
Chart Sales Value of Dezocine Injection over the World
Chart Sales Value of Dezocine Injection in China, 2016-2020
Chart Sales Value of Dezocine Injection in China by Regions, 2016-2020
Chart Sales Volume of Dezocine Injection in China, 2016-2020
Chart Sales Volume of Dezocine Injection in China by Regions, 2016-2020
Chart Market Share by Sales Value of Dezocine Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Jialuoning in China, 2016-2020
Chart Sales Value and Volume of Yikeding in China, 2016-2020
Chart Referential Prices of Jialuoning in China, 2020-2021
Chart Referential Prices of Yikeding in China, 2020-2021
Chart Forecast on Sales Value of Dezocine in China, 2021-2025
Chart Forecast on Sales Volume of Dezocine in China, 2021-2025


More Publications